Mountain Valley MD Files Patent for Novel Vaccine Dose Sparing Adjuvant
Canada NewsWire MVMD immediately proceeding with selection of Contract Research Organization to conduct adjuvant IPV studyTORONTO,Jan. 20, 2021/CNW/ –Mountain Valley
Read moreCanada NewsWire MVMD immediately proceeding with selection of Contract Research Organization to conduct adjuvant IPV studyTORONTO,Jan. 20, 2021/CNW/ –Mountain Valley
Read moreCanada NewsWire VICTORIA, BC, Nov. 19, 2020 VICTORIA, BC, Nov. 19, 2020/CNW/ – IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSXV:
Read moreNutra Pharma Provides Updates on Progress of their Nerve Agent Countermeasures Nutra Pharma is providing updates on their work in
Read moreSAN FRANCISCO, Dec. 7, 2020/CNW/ — PostEra, a biotechnology company specializing in machine learning solutions for preclinical drug discovery, today
Read moreCanada NewsWire LONDON, Nov. 26, 2020 LONDON, Nov. 26, 2020/CNW/ — Haoma Medica announced today the completion of a first-in-human trial
Read more